Agilon Health Investors Reminded of March 2 Lead-Plaintiff Deadline in Securities Case
Fresh notices urge investors to seek leadership roles over allegations of misleading 2025 guidance.
Overview
- Rosen Law Firm and Levi & Korsinsky issued new reminders to agilon health, inc. shareholders about the securities class action covering purchases between February 26, 2025 and August 4, 2025.
- Investors seeking to serve as lead plaintiff must move the court by March 2, 2026, with Rosen stating it first filed the case.
- The complaints allege agilon recklessly issued 2025 guidance that was not achievable and overstated the immediate benefits of risk-reduction 'strategic actions.'
- Rosen notes that no class has been certified and that investors are not represented by counsel unless they retain one.
- Kuehn Law separately announced an investigation into potential fiduciary-duty issues involving certain agilon officers and directors.